Hola,
¿eres nuevo aquí?

Regístrate gratis y conecta tu empresa con financiación pública, partners y proyectos.

Tengo cuenta

Regístrate

Ver video

Micro Pancreas

Financiado

Cerrado

Cure Diabetes by Injection of Micro Pancreas Cell Therapy

Diabetes is a constantly growing concern in Europe and worldwide. Patients with Diabetes suffer from lack of insulin production. Without it, glucose remains in the blood and causes significant complications that can be both short... ver más

29/02/2024

Betalin Therapeuti...

4M€

Presupuesto del proyecto: 4M€

Líder del proyecto

BETALIN THERAPEUTICS LTD No se ha especificado una descripción o un objeto social para esta compañía.

TRL 4-5

Fecha límite participación Sin fecha límite de participación.

Ver 2 Participantes

Financiación concedida El organismo H2020 notifico la concesión del proyecto el día 2024-02-29

EIC-SMEInst-2018-2020: SME instrument

I+D

Cerrada hace 7 años

0% 70% 100%

Información adicional privada

No hay información privada compartida para este proyecto. Habla con el coordinador.

2 Participantes

Betalin Therapeutics

2.45M€ | Lider

235.00K€ | Participante

Conecta tu I+D

¿Tienes un proyecto y buscas un partner? Gracias a nuestro motor inteligente podemos recomendarte los mejores socios y ponerte en contacto con ellos. Te lo explicamos en este video

Proyectos interesantes

VANGUARD New Generation Cell Therapy Bioartificial Pancreas to Cure... 7M€ Cerrado

SAF2008-02469 REGENERACION DE CELULAS BETA PRODUCTORAS DE INSULINA 146K€ Cerrado

Neobetacell Neogenesis of new functional Beta Cells through Modulation o... 1M€ Cerrado

Merlin MEtabolic Cell Reprogramming for the Recovery of Lost INsuli... 2M€ Cerrado

EEBB-I-12-04567 REGENERACION DE CELULAS BETA PRODUCTORAS DE INSULINA 6K€ Cerrado

EYELETS A regenerative medicine approach in diabetes. 3M€ Cerrado

Duración del proyecto: 42 meses Fecha Inicio: 2020-08-19
Fecha Fin: 2024-02-29

Líder del proyecto

BETALIN THERAPEUTICS LTD No se ha especificado una descripción o un objeto social para esta compañía.

TRL 4-5

Presupuesto del proyecto 4M€

Fecha límite de participación Sin fecha límite de participación.

Descripción del proyecto Diabetes is a constantly growing concern in Europe and worldwide. Patients with Diabetes suffer from lack of insulin production. Without it, glucose remains in the blood and causes significant complications that can be both short term -seizures and fainting that could result in coma or even death, and long-term - stroke, heart disease, blindness, kidney failure and limb amputation. Betalin is developing a biologic cure to Diabetes: the Micro Pancreas that after implantation under the skin (by injection) restores natural insulin production and blood glucose regulation. Micro Pancreas is a revolutionary regenerative micro-organ, based on cell therapy comprising a proprietary organ derived 3D scaffold – Micro-Organ Matrix (MOM), isolated human pancreatic islets from donors and MSCs, which reduce the risk of immune response in patients and improve the islet viability and function. Micro Pancreas eliminates insulin dependency in diabetes patients, removing the need for daily injections and injections correlated with meals, constant blood glucose monitoring and dietary constraints. Instead, patients get a biological implant by injection of Micro Pancreas, that generates insulin naturally in response to glucose, improving considerably daily life of patients with diabetes, including children with Type 1 Diabetes and moreover, preventing the long-term complications caused by the disease. Following successful feasibility studies conducted thanks to the European Commission (EC) through SME Instrument Phase 1, a growing market was identified for Micro Pancreas, due to the increasing prevalence of diabetes worldwide. Total market value is expected to more than double from $6.6B in 2013, reaching a value of ~$13.6B by 2023 in drug and treatment sales, with a CAGR of 7.6%. Betalin's project will help ease the economic burden of diabetes in National Health Services while positioning itself as a leading company in the treatment of Diabetes worldwide.

Conecta tu I+D

Entra hoy

¿Olvidé mi contraseña?

Financiación

Empresas

CTIs/Universidades

Proyectos

Investigadores